US 10695308
Inhalation formulations of treprostinil
granted A61KA61K31/19A61K31/191
Quick answer
US patent 10695308 (Inhalation formulations of treprostinil) held by United Therapeutics Corporation expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/19, A61K31/191, A61K31/192, A61K31/201